Cite
[[sup 18] F]FDG in childhood lymphoma: clinical utility and impact on management.
MLA
Montravers, F., et al. “[[Sup 18] F]FDG in Childhood Lymphoma: Clinical Utility and Impact on Management.” European Journal of Nuclear Medicine & Molecular Imaging, vol. 29, no. 9, Sept. 2002, p. 1155. EBSCOhost, https://doi.org/10.1007/s00259-002-0861-y.
APA
Montravers, F., McNamara, D., Landman-Parker, J., Grahek, D., Kerrou, K., Younsi, N., Wioland, M., Leverger, G., & Talbot, N. (2002). [[sup 18] F]FDG in childhood lymphoma: clinical utility and impact on management. European Journal of Nuclear Medicine & Molecular Imaging, 29(9), 1155. https://doi.org/10.1007/s00259-002-0861-y
Chicago
Montravers, F., D. McNamara, J. Landman-Parker, D. Grahek, K. Kerrou, N. Younsi, M. Wioland, G. Leverger, and N. Talbot. 2002. “[[Sup 18] F]FDG in Childhood Lymphoma: Clinical Utility and Impact on Management.” European Journal of Nuclear Medicine & Molecular Imaging 29 (9): 1155. doi:10.1007/s00259-002-0861-y.